col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


35 Ergebisse       Seite 1

 [1] 
Oxford University Press: JAC-Antimicrobial Resistance
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―24 P25. Characteristics, treatment options, and predictors of clinical failure among Pseudomonas aeruginosa infection with microbiologically confirmed intermediate or resistant carbapenem susceptibility profile: a multicenter clinical experience on behalf of CASPER (CArbapenem-reSistant Pseudomonas aERuginosa during and after the COVID-19 pandemic) study group A Dessilani, S Kaleci, G Orlando, M Del Monte, A Bedini, E Franceschini, et al. (+14)
2 [GO] 2025―Jan―23 P01 Cluster randomized controlled trial (RCT) of Air Filtration to prevent Respiratory Infections (including COVID-19) in care homes: the AFRI-c trial Alastair Hay, Rachel Brierley, Nick Turner, Joanna Thorn, Sophie Rees, Jodi Taylor, et al. (+11)
3 [GO] 2024―Aug―23 O04 UKHSA Start Smart Then Focus antimicrobial stewardship: effective implementation during the COVID-19 pandemic at an NHS Foundation Trust in the UK Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
4 [GO] 2024―Aug―23 P11 Pharmacists’ knowledge, attitudes and perceptions towards antimicrobial stewardship and resistance during the COVID-19 pandemic at secondary care settings in the UK Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
5 [GO] 2024―Jun―11 Antibiotic prescribing and bacterial infection in COVID-19 inpatients in Southeast Asia: a systematic review and meta-analysis Achiraya Chanapal, Hung-Yung Cheng, Helen Lambert, Wenjuan Cong
6 [GO] 2024―Mai―27 Antibiotic utilization patterns in Tanzania: a retrospective longitudinal study comparing pre- and intra-COVID-19 pandemic era using Tanzania Medicines and Medical Devices Authority data Raphael Z Sangeda, Sahani M William, Faustine C Masatu, Adonis Bitegeko, Yonah H Mwalwisi, Emmanuel A Nkiligi, et al. (+2)
7 [GO] 2024―Apr―24 Comparing indicators of disease severity among patients presenting to hospital for urinary tract infections before and during the COVID-19 pandemic Selina Patel, Martin Gill, Andrew Hayward, Susan Hopkins, Andrew Copas, Laura Shallcross
8 [GO] 2024―Feb―22 Hospital prescribing patterns of antibiotics in Zambia using the WHO prescribing indicators post-COVID-19 pandemic: findings and implications Steward Mudenda, Robert Chilimboyi, Scott Kaba Matafwali, Victor Daka, Ruth Lindizyani Mfune, Loriane Arielle Mobou Kemgne, et al. (+5)
9 [GO] 2024―Feb―07 Should we stop referring to the pandemic of antimicrobial resistance as silent? Miroslav Sirota
10 [GO] 2024―Feb―07 Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis Sidra Khan, Stuart E Bond, Jade Lee-Milner, Barbara R Conway, William J Lattyak, Mamoon A Aldeyab
11 [GO] 2023―Nov―13 Antimicrobial prescribing in a secondary care setting during the COVID-19 pandemic Michael M Tadros, Marian S Boshra, Michael Scott, Glenda Fleming, Fidelma Magee, Mohammad I Hamed, et al. (+4)
12 [GO] 2023―Aug―02 P16 COVID-19 and urinary tract infection: the main manifestations and their management Kiarina Chichirelo-Konstantynovych, Tetyana Konstantynovych
13 [GO] 2023―Aug―02 P15 Women’s satisfaction with the management of urinary tract infections during the COVID-19 pandemic: a qualitative analysis of free-text comments from a national survey in England A’mar Dababneh, Leigh Sanyaolu, Haroon Ahmed, Dushyanthi Alagiyawanna, Donna Lecky, Emily Cooper
14 [GO] 2023―Jul―17 The impact of COVID-19 national restrictions on dental antibiotic dispensing trends and treatment activity in England: January 2016 to July 2021 Angela Falola, Alicia Demirjian, Wendy Thompson, Colin S Brown, Sarah Gerver, Sabine Bou-Antoun
15 [GO] 2023―Jun―14 P17 Aetiology of hospital-acquired Gram-negative bacteraemias over the COVID-19 pandemic: a single NHS Trust experience, UK Syra Dhillon, Oscar Buchanan, Catherine Sargent
16 [GO] 2023―Jun―09 Knowledge, attitude and practice of healthcare workers towards antibiotic resistance during the COVID-19 pandemic Hadi Al Sulayyim, Rohani Ismail, Abdullah Al Hamid, Noraini Abdul Ghafar
17 [GO] 2023―Feb―11 Sustained increases in antibiotic prescriptions per primary care consultation for upper respiratory tract infections in England during the COVID-19 pandemic Zheyuan Yang, Sabine Bou-Antoun, Sarah Gerver, Thomas E Cowling, Rachel Freeman
18 [GO] 2023―Jan―19 P16 Overuse of antibiotics during the first year of the COVID-19 pandemic in Poland Izabella Owsianka, Mateusz Gajda, Paweł Krzyściak, Barbara Gryglewska, Anna Różańska, Jadwiga Wójkowska-Mach
19 [GO] 2022―Dez―13 A cross-sectional study of hospital antimicrobial stewardship programmes in the COVID-19 era Valerie Leung, Jacquelyn Quirk, Sarah Muir, Nick Daneman, Kevin L Schwartz, Bradley J Langford
20 [GO] 2022―Dez―07 The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review Lucy S Witt, Jessica R Howard-Anderson, Jesse T Jacob, Lindsey B Gottlieb
21 [GO] 2022―Jun―16 Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Valentina Galfo, Sara Occhineri, Stefano Verdenelli, et al. (+23)
22 [GO] 2022―Jun―01 P12 Antibiotic prescribing in hospitalized patients with COVID-19 as a function of inflammatory markers in Wave 1 versus Wave 2: a systematic review Saif Abbas Chatoo, Emma Thomas-Jones, Philip Pallmann, Joanne Euden
23 [GO] 2022―Jun―01 P05 The impact of COVID-19 on antifungal stewardship in a UK tertiary teaching hospital: a review of prescribing practices and therapeutic drug monitoring of posaconazole Adam Andreani, Netta Tyler, Christiane Micallef, David Enoch, Vanessa Wong
24 [GO] 2022―Mrz―16 Antibiotic resistance: calling time on the ‘silent pandemic’ Marc Mendelson, Michael Sharland, Mirfin Mpundu
25 [GO] 2022―Feb―16 P36 Procalcitonin as an antimicrobial stewardship tool in the COVID-19 era: a single centre experience Margaret Creedon, Alida Fe Talento, Roisin Connolly, Aine Egan, Tidi Hassan, Marta Trzos-Grzybowksa
26 [GO] 2022―Feb―16 P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study Joanne Euden, Philip Howard, Neil Powell, Martin J. Llewelyn, Tamas Szakmany, Mahableswhar Albur, et al. (+17)
27 [GO] 2022―Feb―16 O03 The impact of COVID-19 infection prevention and control measures on transmission of hospital-acquired infections and antimicrobial resistance in Africa Linzy Elton, Muzamil M. Abdel Hamid, John Tembo, Hana Elbadawi, Kwitaka Maluzi, Mohamed H. Abdelraheem, et al. (+5)
28 [GO] 2022―Feb―16 P12 Important early prognostic laboratory indicators for COVID-19 mortality Ergys Ramosaço, Entela Kolovani, Nevila Gjermeni, Najada Çomo
29 [GO] 2022―Feb―16 P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship Lois Hawkins, Ting Yau, Tihana Bicanic, Marina Basarab
30 [GO] 2022―Feb―16 P27 Bacterial coinfection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis Maria Calderon, Grace Gysin, Sarah Walpole, Felicity Mills, Daniel Comandé, Ewan Hunter
31 [GO] 2022―Feb―16 P30 Bacterial coinfection and prescribing trends in SARS-CoV-2 infection in two UK hospitals P. J. Teoh, I. Maan, J. Uwagwu, A. Odedra
32 [GO] 2021―Sep―07 Educational Resource Review: MSD’s The Steward-Episode 6-The impact of COVID-19 on AMS
33 [GO] 2021―Aug―28 Erratum to: Education: The role of the first siderophore cephalosporin Fetcroja® (cefiderocol) in UK clinical practice: introduction; Antibiotic resistance during and beyond COVID-19; Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice; Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa; Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection; Education: An overview from the author of ‘Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients’
34 [GO] 2020―Dez―09 Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection Liam Townsend, Gerry Hughes, Colm Kerr, Mary Kelly, Roisin O’Connor, Eileen Sweeney, et al. (+5)
35 [GO] 2020―Apr―08 Infection prevention and control (IPC) for novel coronavirus (COVID-19)
 [1] 

35 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.146 sec